These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6335447)

  • 1. Failure to influence the VIP level in the cerebrospinal fluid by transcutaneous nerve stimulation in humans.
    Kaada B; Hegland O; Oktedalen O; Opstad PK
    Gen Pharmacol; 1984; 15(6):563-5. PubMed ID: 6335447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In search of mediators of skin vasodilation induced by transcutaneous nerve stimulation: III. Increase in plasma VIP in normal subjects and in Raynaud's disease.
    Kaada B; Olsen E; Eielsen O
    Gen Pharmacol; 1984; 15(2):107-13. PubMed ID: 6714637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower plasma levels of some gastrointestinal peptides in Raynaud's disease. Influence of transcutaneous nerve stimulation.
    Kaada B; Lygren I
    Gen Pharmacol; 1985; 16(2):153-6. PubMed ID: 3873378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of itching and atopic eczema by transcutaneous nerve stimulation.
    Bjørnå H; Kaada B
    Acupunct Electrother Res; 1987; 12(2):101-12. PubMed ID: 2890272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic inactivation of vasoactive intestinal peptide in man and dog.
    Ebeid AM; Escourrou J; Soeters PB; Murray P; Fischer JE
    Ann Surg; 1978 Jul; 188(1):28-33. PubMed ID: 666373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased vasoactive intestinal polypeptide (VIP) level in cerebrospinal fluid from diabetic patients with neuropathy.
    Umeda F; Noda K; Ono H; Chijiiwa Y; Nawata H
    Fukuoka Igaku Zasshi; 1991 Jan; 82(1):17-20. PubMed ID: 2022357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of esophageal dysmotility and Raynaud's phenomenon in systemic sclerosis and achalasia by transcutaneous nerve stimulation. Increase in plasma VIP concentration.
    Kaada B
    Scand J Gastroenterol; 1987 Nov; 22(9):1137-46. PubMed ID: 3501154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of transcutaneous nerve stimulation on esophageal function in normal subjects--evidence for a somatovisceral reflex.
    Chang FY; Chey WY; Ouyang A
    Am J Chin Med; 1996; 24(2):185-92. PubMed ID: 8874676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide in cerebrospinal fluid.
    Sharpless NS; Thal LJ; Perlow MJ; Tabaddor K; Waltz JM; Shapiro KN; Amin IM; Engel J; Crandall PH
    Peptides; 1984; 5(2):429-33. PubMed ID: 6473166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of transcutaneous nerve stimulation on sphincter of Oddi pressure in patients with biliary dyskinesia.
    Guelrud M; Rossiter A; Souney PF; Mendoza S; Mujica V
    Am J Gastroenterol; 1991 May; 86(5):581-5. PubMed ID: 2028948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal polypeptide (VIP) in cerebrospinal fluid from men after long-term exposure to organic solvents.
    Johansson BB; Ben-Menachem E; Ekberg K; Wikkelsø C; Fahrenkrug J
    Acta Neurol Scand; 1984 Oct; 70(4):317-8. PubMed ID: 6507041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid (CSF) extracted immediately after REM sleep deprivation prevents REM rebound and contains vasoactive intestinal peptide (VIP).
    Jiménez-Anguiano A; Báez-Saldaña A; Drucker-Colín R
    Brain Res; 1993 Dec; 631(2):345-8. PubMed ID: 8131065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In search of mediators of skin vasodilation induced by transcutaneous nerve stimulation: IV. In vitro bioassay of the vasoinhibitory activity of sera from patients suffering from peripheral ischaemia.
    Kaada B; Helle KB
    Gen Pharmacol; 1984; 15(2):115-22. PubMed ID: 6714638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical study of cerebrospinal fluid neuropeptides in patients with primary trigeminal neuralgia.
    Qin ZL; Yang LQ; Li N; Yue JN; Wu BS; Tang YZ; Guo YN; Lai GH; Ni JX
    Clin Neurol Neurosurg; 2016 Apr; 143():111-5. PubMed ID: 26918582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIP in cerebrospinal fluid of patients with multiple sclerosis.
    Andersen O; Fahrenkrug J; Wikkelsø C; Johansson BB
    Peptides; 1984; 5(2):435-7. PubMed ID: 6473167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in plasma vasoactive intestinal polypeptide (VIP) in muscular exercise in humans.
    Woie L; Kaada B; Opstad PK
    Gen Pharmacol; 1986; 17(3):321-6. PubMed ID: 3721187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal polypeptides in connective tissue massage. With a note on VIP in heat pack treatment.
    Kaada B; Torsteinbø O
    Gen Pharmacol; 1987; 18(4):379-84. PubMed ID: 3609696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acupuncture on vasoactive intestinal peptide in ischemic cerebrovascular diseases.
    Zhang X; Yuan Y; Kuang P; Wu W; Zhang F; Liu J
    J Tradit Chin Med; 1997 Dec; 17(4):289-93. PubMed ID: 10437215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcutaneous nerve stimulation in patients with coronary arterial disease: haemodynamic and biochemical effects.
    Kaada B; Vik-mo H; Rosland G; Woie L; Opstad PK
    Eur Heart J; 1990 May; 11(5):447-53. PubMed ID: 2354706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of autonomic stimulation on the release of vasoactive intestinal peptide from the gastrointestinal tract in the calf.
    Bloom SR; Edwards AV
    J Physiol; 1980 Feb; 299():437-52. PubMed ID: 6991667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.